A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04718896 · COMPLETED
Trial details
- NCT number
- NCT04718896
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2025-03-12
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.